These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31307889)

  • 1. Modifications of the AJCC 8th edition staging system for intrahepatic cholangiocarcinoma and proposal for a new staging system by incorporating serum tumor markers.
    Cheng Z; Lei Z; Si A; Yang P; Luo T; Guo G; Zhou J; Wang X; Li Z; Xia Y; Li J; Wang K; Yan Z; Wei W; Hartmann D; Hüser N; Lau WY; Shen F
    HPB (Oxford); 2019 Dec; 21(12):1656-1666. PubMed ID: 31307889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposed modification of the eighth edition of the AJCC staging system for intrahepatic cholangiocarcinoma.
    Zhang XF; Xue F; He J; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Lv Y; Pawlik TM
    HPB (Oxford); 2021 Sep; 23(9):1456-1466. PubMed ID: 33814298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the AJCC 8th Edition Staging System for Pathologically Versus Clinically Staged Intrahepatic Cholangiocarcinoma (iCCA): a Time to Revisit a Dogma? A Surveillance, Epidemiology, and End Results (SEER) Analysis.
    Kamarajah SK
    J Gastrointest Cancer; 2019 Sep; 50(3):392-399. PubMed ID: 29512000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified staging classification for intrahepatic cholangiocarcinoma based on the sixth and seventh editions of the AJCC/UICC TNM staging systems.
    Meng ZW; Pan W; Hong HJ; Chen JZ; Chen YL
    Medicine (Baltimore); 2017 Aug; 96(34):e7891. PubMed ID: 28834905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: A surveillance, epidemiology, and end results (SEER) analysis.
    Kim Y; Moris DP; Zhang XF; Bagante F; Spolverato G; Schmidt C; Dilhoff M; Pawlik TM
    J Surg Oncol; 2017 Nov; 116(6):643-650. PubMed ID: 28608424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma.
    Spolverato G; Bagante F; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Pawlik TM
    J Surg Oncol; 2017 May; 115(6):696-703. PubMed ID: 28194791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposal and validation of a modified staging system to improve the prognosis predictive performance of the 8th AJCC/UICC pTNM staging system for gastric adenocarcinoma: a multicenter study with external validation.
    Fang C; Wang W; Deng JY; Sun Z; Seeruttun SR; Wang ZN; Xu HM; Liang H; Zhou ZW
    Cancer Commun (Lond); 2018 Nov; 38(1):67. PubMed ID: 30454049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk prediction in intrahepatic cholangiocarcinoma: Direct comparison of the MEGNA score and the 8th edition of the UICC/AJCC Cancer staging system.
    Hahn F; Müller L; Mähringer-Kunz A; Schotten S; Düber C; Hinrichs JB; Maschke SK; Galle PR; Bartsch F; Lang H; Weinmann A; Kloeckner R
    PLoS One; 2020; 15(2):e0228501. PubMed ID: 32012198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic comparison of the 7th and 8th editions of the American Joint Committee on Cancer staging system for intrahepatic cholangiocarcinoma.
    Kang SH; Hwang S; Lee YJ; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Lee SG
    J Hepatobiliary Pancreat Sci; 2018 Apr; 25(4):240-248. PubMed ID: 29450978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposal of the optimal numbers of examined and positive lymph nodes to the 8th edition of American Joint Committee on Cancer (AJCC) staging for 758 patients with distal cholangiocarcinoma.
    Wu R; Zhang G; Feng J; Zhang L; Yang Z
    PLoS One; 2020; 15(6):e0234464. PubMed ID: 32544187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic predictability of the new American Joint Committee on Cancer 8th staging system for distal bile duct cancer: limited usefulness compared with the 7th staging system.
    Kang JS; Lee S; Son D; Han Y; Lee KB; Kim JR; Kwon W; Kim SW; Jang JY
    J Hepatobiliary Pancreat Sci; 2018 Feb; 25(2):124-130. PubMed ID: 29239127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum tumor markers enhance the predictive power of the AJCC and LCSGJ staging systems in resectable intrahepatic cholangiocarcinoma.
    Sasaki K; Margonis GA; Andreatos N; Chen Q; Barbon C; Bagante F; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Endo I; Aucejo FN; Pawlik TM
    HPB (Oxford); 2018 Oct; 20(10):956-965. PubMed ID: 29887261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and Recommendation of the 8th Edition of American Joint Committee on Cancer (AJCC) Staging System for Intrahepatic Cholangiocarcinoma (ICC) in 820 Patients from the Surveillance, Epidemiology, and End Results (SEER) Database.
    RuiYang W; ZhiMing Y; Jiao F; Liang Z; Gang Z
    J Gastrointest Surg; 2021 Jan; 25(1):145-154. PubMed ID: 32193847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External validation of a modified 8th AJCC TNM system for advanced gastric cancer: Long-term results in southern China.
    Ye J; Ren Y; Wei Z; Hou X; Dai W; Cai S; Tan M; He Y; Yuan Y
    Surg Oncol; 2018 Jun; 27(2):146-153. PubMed ID: 29937164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of liver resection on survival for locally advanced intrahepatic cholangiocarcinoma tumors: A propensity score analysis.
    Moustafa M; Fasolo E; Bassi D; D'amico FE; Gringeri E; Pawlik TM; Cillo U
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):632-637. PubMed ID: 31812289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AJCC 7th edition staging classification is more applicable than AJCC 8th edition staging classification for invasive IPMN.
    Fan Z; Cheng H; Jin K; Gong Y; Huang Q; Xu J; Ni Q; Yu X; Liu C; Luo G
    World J Surg Oncol; 2019 Aug; 17(1):137. PubMed ID: 31387646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic cholangiocarcinoma: the AJCC/UICC 8th edition updates.
    Lee AJ; Chun YS
    Chin Clin Oncol; 2018 Oct; 7(5):52. PubMed ID: 30180751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AJCC 8th Edition Staging System for Soft Tissue Sarcoma of the Extremities or Trunk: A Cohort Study of the SEER Database.
    Cates JMM
    J Natl Compr Canc Netw; 2018 Feb; 16(2):144-152. PubMed ID: 29439175
    [No Abstract]   [Full Text] [Related]  

  • 19. Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo Clinic experience.
    Ali SM; Clark CJ; Mounajjed T; Wu TT; Harmsen WS; Reid-Lombardo KM; Truty MJ; Kendrick ML; Farnell MB; Nagorney DM; Que FG
    HPB (Oxford); 2015 Mar; 17(3):244-50. PubMed ID: 25410716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proposal of a modified American Joint Committee on Cancer staging scheme for resectable pancreatic ductal adenocarcinoma with a lymph node ratio-based N classification: A retrospective cohort study.
    Li HJ; Chen YT; Yuan SQ
    Medicine (Baltimore); 2018 Aug; 97(34):e12094. PubMed ID: 30142869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.